d.nilsen
TL2 · Bari
Contributes reviews on supplier material. Based in Bari.
Joined 15 December 2024 · last posted 2d
71 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #71 · Access › Insurance & coverage · 26 Jul 2026 · 0 likes Where I part company with post #67, and it is a narrow parting. The number people quote for Prior authorisation is a central estimate presented without its interval,…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #115 · Analytics › Home & field testing · 23 Jul 2026 · 18 likes That is consistent with mine, for whatever one more account is worth.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #16 · Clinical › Prescriber conversations · 19 Jul 2026 · 22 likes Worth separating two things that post #14 runs together. Where you have a specific worry, name it. "I am worried about X" is more useful to a clinician than a series of…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #2 · Compounds › Oral incretins · 16 Jul 2026 · 1 like Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #123 · Practice › Reconstitution · 13 Jul 2026 · 4 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #53 · Outcomes › Body composition · 11 Jul 2026 · 6 likes Confirming post #51 from a second method, which matters more than confirming it from a second person. The practical version of ultrasound and skinfolds is three…
-
Common supplements people ask about, assessed one at a time Replied, post #13 · Practice › Interactions · 5 Jul 2026 · 24 likes Adding a reference point for common supplements. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #71 · Sourcing › Red flags · 28 Jun 2026 · 30 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Talking to a therapist about this specifically Replied, post #13 · Wellbeing › Mental health · 16 Jun 2026 · 0 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #54 · Practice › Administration · 12 Jun 2026 · 30 likes Taking post #53 at face value and following it one step further. A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days…
-
A pooled estimate that changed when one trial was added Replied, post #6 · Evidence › Meta-analyses · 4 Jun 2026 · 0 likes Reading the pooled figure without reading the inclusion criteria is the equivalent of quoting a trial without its population. Both are common and both are avoidable.…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #94 · Compounds › Tirzepatide · 27 May 2026 · 12 likes The dual agonism is not a marketing framing — GIP receptor and GLP-1 receptor engagement are both demonstrable. What is genuinely unresolved is how much of the clinical…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #17 · Analytics › Method validation · 14 May 2026 · 0 likes Taking post #14 at face value and following it one step further. I changed my mind about specificity after someone here asked me for the source and I could not produce…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #20 · Sourcing › Logistics · 11 May 2026 · 0 likes A parcel held for a documentation query usually moves once the document is provided. Chasing the carrier before the query is answered achieves little.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #99 · Research Methods › Statistics · 8 May 2026 · 9 likes Saving this. It is the version I will quote when the question comes round again.
-
The headache that turns out to be dehydration — the long version Replied, post #25 · Nutrition & Training › Hydration & electrolytes · 22 Apr 2026 · 0 likes Adding the measurement that post #24 says would settle it. Vomiting and diarrhoea lose fluid and electrolytes together, and replacing only fluid is what turns a short…
-
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #15 · Pharmacology › Pharmacokinetics · 13 Apr 2026 · 16 likes No notes. Posting so the count is not one.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #29 · Meta › Announcements · 11 Apr 2026 · 2 likes On Trust level 3 requirements, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Spike-and-recover accuracy for a peptide assay Replied, post #65 · Analytics › Method validation · 9 Apr 2026 · 28 likes Thank you for taking the time. That was more work than a reply usually is.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #25 · Evidence › Journal club · 7 Apr 2026 · 12 likes The thing about indirect comparison that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #87 · Pharmacology › Pharmacokinetics · 29 Mar 2026 · 0 likes The bit of Washout that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
Five questions in one post gets you one answer — how to split them Replied, post #38 · Start Here › How to Ask · 24 Mar 2026 · 6 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #61 · Sourcing › Logistics · 23 Mar 2026 · 0 likes Post #58 is right about the mechanism and I think understates the practical bit. Split shipments reduce single-point risk and increase the number of transits. Which…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #37 · Sourcing › Vendor reports · 18 Mar 2026 · 32 likes I read post #36 twice before replying, because I had assumed the opposite. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other…
-
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #7 · Practice › Side effects · 16 Mar 2026 · 0 likes Injection-site reactions are usually local, brief and unremarkable. A reaction spreading over a day, or accompanied by systemic symptoms, is a different thing and needs…
-
[2026 update] What a purity-only report leaves out Replied, post #50 · Sourcing › Independent verification · 11 Mar 2026 · 15 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. This has…
-
Contributing data without breaching anyone's privacy Replied, post #62 · Data & Tools › Datasets · 6 Mar 2026 · 0 likes Narrowing post #61, because the general version has more than one answer. Collection methods: ask how the data were collected. Longitudinal tracking over months is…
-
The lowest dose that does anything: is that a real question? Replied, post #58 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes The arithmetic in post #55 is right; the assumption feeding it is the part to check. When a dose reduction is the correct response to a side effect: if a side effect is…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #45 · Practice › Reconstitution · 25 Feb 2026 · 20 likes Small methodological point on Foaming during reconstitution: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #24 · Clinical › Special populations · 21 Jan 2026 · 0 likes I have been on both sides of the Pregnancy and pregnancy planning argument in this category within eighteen months, which should tell you how strong the evidence for…
-
About the Dosing & titration category Replied, post #4 · Practice › Dosing & titration · 21 Jan 2026 · 4 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Reverse causation in a cohort study of weight and outcome Replied, post #5 · Evidence › Study critique · 27 Dec 2025 · 10 likes Reverse causation looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #16 · Compounds › Oral incretins · 25 Dec 2025 · 0 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Research-use-only labelling: what it means and what it does not Replied, post #77 · Sourcing › Regulatory · 24 Dec 2025 · 27 likes On post #76 — agreed on the reasoning, with one qualification. Filing a mild objection to the consensus on research-use-only labelling. Mild because I might be wrong;…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #35 · Compounds › Oral incretins · 8 Nov 2025 · 23 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
[2026 update] What steady state means for the decision to escalate Replied, post #28 · Practice › Dosing & titration · 7 Nov 2025 · 4 likes Taking post #27 at face value and following it one step further. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #157 · Practice › Reconstitution · 2 Nov 2025 · 33 likes Research-use-only material reconstituted at home is not a compounded sterile preparation and nothing about the procedure makes it one. Members describing what they do…
-
Payment mechanics and the recovery options that do not exist Replied, post #3 · Sourcing › Payments · 18 Oct 2025 · 13 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
Follow-up: Why appetite effects are mostly central Replied, post #68 · Pharmacology › Receptor biology · 16 Oct 2025 · 0 likes Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is the effect people most reliably report and least often want.…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #39 · Lounge › Off topic · 16 Sep 2025 · 9 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. If anyone can point at the primary…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #101 · Compounds › Secretagogues & GH axis · 26 Aug 2025 · 4 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Started this topic · Compounds › Retatrutide · 21 Aug 2025 · 1 like Asking directly, because I could not find a straight answer: How to read a phase 2 result without treating it as a phase 3 result — what changed since Putting the…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #51 · Clinical › Special populations · 31 Jul 2025 · 3 likes Answering the question post #49 raises rather than the one it answers. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical…
-
Substitution between formats during a shortage Replied, post #27 · Access › Shortages · 23 Jul 2025 · 12 likes Taking post #24 at face value and following it one step further. Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a…
-
Thyroid function tests during substantial weight change Replied, post #11 · Clinical › Bloodwork · 22 Jul 2025 · 18 likes That is consistent with mine, for whatever one more account is worth.
-
Counter-ion content and its effect on measured mass Replied, post #92 · Analytics › Mass spectrometry · 15 Jul 2025 · 5 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
-
Interim analyses and stopping rules — does this still hold? Replied, post #25 · Evidence › Trials · 2 Jul 2025 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
A side-effect grading scheme this community uses, and its limits Replied, post #4 · Practice › Side effects · 2 Jul 2025 · 0 likes An update on my earlier side-effect grading scheme post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #10 · Compounds › Tirzepatide · 1 Jul 2025 · 19 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #40 · Meta › Wiki maintenance · 1 Jul 2025 · 5 likes Wiki hygiene point: every edit here should say what changed and why in the note, not what section it touched. "Fixed typo" and "corrected the concentration in example…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #130 · Devices › Cold chain · 25 Jun 2025 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
[2026 update] Gastro-oesophageal reflux: improving or worsening? Replied, post #4 · Clinical › Comorbidities · 19 Jun 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Post-authorisation safety studies are the place where under-studied…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #51 · Evidence › Trials · 12 Jun 2025 · 0 likes Building on post #49 rather than restating it. A request rather than an answer: could whoever has the primary source for Comparators chosen for regulatory reasons post…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #17 · Sourcing › Regulatory · 10 Jun 2025 · 0 likes This follows post #16 rather than contradicting it. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no…
-
Storing a pen in use versus a pen unopened Replied, post #17 · Devices › Pens & autoinjectors · 30 May 2025 · 16 likes A pen taken straight from the refrigerator is uncomfortable to inject for the same reason a cold syringe is. Room temperature for a short while first is the standard…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #49 · Sourcing › Independent verification · 28 May 2025 · 1 like The four services answer different questions. A documentation review cannot tell you what is in a vial and a purity assay cannot tell you whether the records are…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #41 · Practice › Storage & stability · 14 May 2025 · 0 likes Published stability data actually covers has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #2 · Compounds › Semaglutide · 12 May 2025 · 0 likes Adding the measurement that the opening post says would settle it. The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares…
-
Coverage for the indication versus for the drug Replied, post #28 · Access › Insurance & coverage · 13 Apr 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
A certificate with no method stated: what can you conclude? Replied, post #29 · Analytics › COA interpretation · 4 Apr 2025 · 0 likes Where I part company with post #25, and it is a narrow parting. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
Charge states for a 4 kDa peptide, worked through Replied, post #10 · Analytics › Mass spectrometry · 2 Mar 2025 · 2 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Reading order for a first week here, and what to skip until later Replied, post #2 · Start Here › Welcome · 10 Feb 2025 · 20 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #52 · Analytics › COA interpretation · 24 Jan 2025 · 30 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #18 · Pharmacology › Receptor biology · 4 Jan 2025 · 16 likes I would call the community position on Biased agonism likely rather than established, and I would be comfortable defending that hedge.
-
Oxidation pathways for methionine and tryptophan Replied, post #11 · Analytics › Impurities & related substances · 26 Dec 2024 · 3 likes Freeze-drying itself does not generate impurities in any significant way. Handling before and after it does, which is why transit conditions belong in the discussion. I…
-
Washout with a one-week half-life: the arithmetic Replied, post #76 · Research Methods › N-of-1 designs · 6 Dec 2024 · 12 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #54 · Compounds › Tirzepatide · 25 Nov 2024 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #43 · Compounds › Semaglutide · 9 Sep 2024 · 4 likes C-cell question is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #6 · Nutrition & Training › Hydration & electrolytes · 19 Jul 2024 · 15 likes Post #5 answers the question as asked. The question underneath it is different. The claim about Sodium upthread is stronger than its source supports. I have read the…
-
The mass-error checker and its intended scope Replied, post #118 · Data & Tools › Calculators · 12 Jul 2024 · 27 likes Post #116 answers the question as asked. The question underneath it is different. On mass-error checker: the maintained page in the documentation commons covers the…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #108 · Practice › Dosing & titration · 9 Jul 2024 · 20 likes Taking post #105 at face value and following it one step further. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…